The Biomedical Research Council (BMRC) oversees 7 research institutes and several other research units that focus on both basic as well as translational and clinical research to support the key industry clusters in Biomedical Sciences: pharmaceuticals, medical technology, biotechnology and healthcare services.

Having established a strong foundation in basic biomedical research capabilities, there is now an added focus on translating new knowledge and technologies created at the "benches" into new clinical applications for diagnosis and treatment that can one day be delivered at the "bedsides" of our hospitals and disease centres.

The research institutes and units under BMRC are:

• Bioinformatics Institute (BII)
• Bioprocessing Technology Institute (BTI)
• Genome Institute of Singapore (GIS)
• Institute of Bioengineering and Nanotechnology (IBN)
• Institute of Medical Biology (IMB)
• Institute of Molecular and Cell Biology (IMCB)
• Singapore Bioimaging Consortium (SBIC)
• Singapore Cancer Syndicate (SCS)
• Singapore Consortium for Cohort Studies (SCCS)
• Singapore Immunology Network (SIgN)
• Singapore Institute for Clinical Sciences (SICS)
• Singapore Stem Cell Consortium (SSCC)

Research Institutes

The BMRC Research Institutes focus on building up core biomedical capabilities in the areas of bioprocessing; chemical synthesis; genomics and proteomics; molecular and cell biology; bioengineering and nanotechnology and computational biology. In addition, the Institute of Medical Biology (IMB) and Singapore Institute for Clinical Sciences (SICS) focus on translational and clinical research. Please click here to find out more.

 
Strategic Initatives: Translational Research

In order to realize the full potential of investments in basic discovery research, BMRC has put in place several intiatives to drive translational and clinical research (TCR) so as to take discoveries from "bench" to "bedside". This includes two new research institutes, the Institute of Medical Biology (IMB) and Singapore Institute for Clinical Sciences (SICS), as well as the Experimental Therapeutics Centre (ETC).

BMRC has also established various consortia to coordinate and drive translational research at the national level in strategic thematic areas. These consortia aim to consolidate existing research activities and scientific expertise, optimize the use of critical research resources, fill in gaps in research capabilities, as well as build sufficient synergy and critical mass to make Singapore’s efforts in these areas internationally competitive. Please click here to find out more.